PolyPid (PYPD) Q2 2026 Earnings Call Transcript
FDA accepts D-PLEX100 application with Priority Review, setting November approval target.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.